Want to see CRL full AI Analyst Report?
Operating Margin by Segment
Reveals the profitability ratio of each segment, offering a view into cost management and pricing power within different areas of the business.Margins across segments are highly volatile, driven more by timing, NHP sourcing costs and portfolio reshaping than steady operational decline; Manufacturing shows a pronounced rebound tied to Microbial demand and cost‑savings despite prior quarter one‑offs from CDMO/divestiture activity, RMS remains lumpy with NHP shipment timing and smaller‑model weakness, and DSA compression reflects higher study costs even as bookings/backlog point to H2 recovery. Management’s $100M+ incremental savings and divestiture benefits should drive most margin expansion in 2H, but near‑term cash and timing risks persist.
Date | Research Models and Services | Discovery and Safety Assessment | Manufacturing Solutions |
|---|---|---|---|
Jun 30, 2026 | 17.30 | 20.50 | 34.90 |
Mar 31, 2026 | 23.90 | 17.40 | 24.60 |
Dec 31, 2025 | -33.60 | 14.30 | -115.90 |
Sep 30, 2025 | 16.20 | 20.50 | 20.90 |
Jun 30, 2025 | 16.80 | 19.90 | 6.00 |
Mar 31, 2025 | 20.50 | 15.90 | -4.80 |
Dec 31, 2024 | 6.70 | 10.40 | -93.60 |
Sep 30, 2024 | 13.90 | 20.60 | 20.40 |
Jun 30, 2024 | 14.50 | 22.10 | 19.40 |
Mar 31, 2024 | 19.50 | 19.00 | 18.20 |